Case report from Mayo Clinic: Locally advanced Bartholin gland carcinoma
By: Melva Pinn, Laura Austin, David Schomas and Robert Miller
Open Access
|Aug 2007References
- Elkas JC, Berek JS. Clinical manifestations, diagnosis, pathology, and staging of vulvar cancer. UpToDate Patient Information [homepage on the Internet]. UpToDate, Inc.; c2007 [cited 2007 Mar 5]. Available from:
- Chen KT. Disorders of Bartholin's gland. UpToDate Patient Information [homepage on the Internet]. UpToDate, Inc.; c2007 [cited 2007 Mar 5]. Available from:
- Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group.1998;: 79-85.
- Han SC, Kim DH, Higgins SA, Carcangiu M-L, Kacinski BM. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva.2000;: 1235-44.
- Rotman M, Lange CS. Anal cancer: radiation and concomitant continuous infusion chemotherapy.1991;: 1385-7.
- Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez Gonzalez D, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.1997;: 2040-9.
- UKCCCR Anal Cancer Trial Working Party, UK Co-ordinating Committee on Cancer Research. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin.1996;: 1049-54.
- Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.1996;: 2527-39.
- Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies.2002;: 1330-7.
- Mundt AJ, Roeske JC, Lujan AE. Intensity-modulated radiation therapy in gynecologic malignancies.2002;: 131-6.
- Mundt AJ, Roeske JC, Lujan AE, Yamada SD, Waggoner SE, Fleming G, et al. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies.2001;: 456-63.
- Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ. Intensity-modulated whole pelvis radiation therapy in patients with gynecologic malignancies.2000;: 1613-21.
- Garofalo MC, Lujan AE, Mundt AJ. Intensity-modulated radiation therapy in the treatment of vulvar carcinoma: a feasibility study [abstract].2002;: 597.
- Mell LK, Schomas DA, Salama JK, et al. Multi-institutional analysis of dosimetric predictors of acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity modulated radiation therapy (IMRT).In press.
- Salama JK, Mell LK, Schomas DA, et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.In press.
Language: English
Page range: 72 - 79
Published on: Aug 6, 2007
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2007 Melva Pinn, Laura Austin, David Schomas, Robert Miller, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.